Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inbody Co., Ltd. (041830:KRX), powered by AI.
Inbody Co., Ltd. is currently trading at ₩45,550. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Inbody Co., Ltd. on Alpha Lenz.
Inbody Co., Ltd.'s P/E ratio is 20.0.
“Inbody Co., Ltd. trades at a P/E of 20.0 (fair value) with solid ROE of 10.4%. 3Y revenue CAGR of 13.5% highlights clear growth momentum.”
Ask for details →Inbody Co., Ltd. is a company that specializes in developing and manufacturing medical and healthcare equipment focused on body composition analysis. The primary function of Inbody is to provide precise and easy-to-use products that assess body composition and health metrics, facilitating accurate assessments of various body components like fat, muscle, and water levels. These analyses are utilized in diverse sectors, including healthcare, fitness, sports medicine, and wellness, empowering professionals and patients alike with actionable insights to improve health outcomes. Inbody's innovative technology plays a crucial role in preventive health strategies, offering critical data for individual health assessments and population health management. Its products are distributed globally and are integral in medical settings, fitness centers, and research institutions. With a commitment to accuracy and reliability, Inbody Co., Ltd. has established itself as a leader in the body composition analysis industry, contributing significantly to advancements in personal health management and clinical diagnostics. In this way, the company holds a vital market position, promoting greater awareness and understanding of body health through technologically advanced solutions.
“Inbody Co., Ltd. trades at a P/E of 20.0 (fair value) with solid ROE of 10.4%. 3Y revenue CAGR of 13.5% highlights clear growth momentum.”
Ask for details →Inbody Co., Ltd. (ticker: 041830) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $614.1B.
The current price is ₩45,550 with a P/E ratio of 20.05x and P/B of 1.93x.
ROE is 10.37% and operating margin is 15.71%. Annual revenue is $233.9B.